12 completed, 3 recruiting, 3 unknown, 2 active not recruiting. 26 Phase 3, 8 Phase 2.
Follow IVIG: new trials by email Literature Review of IVIG trials Research Report on IVIG
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Immunoglobulin Plus Firsekibart in Patients With Kawasaki Disease IVIG, Aspirin, Firsekibart - Kawasaki Disease | Phase 2 / Phase 3 | Not yet recruiting | Children's Hospital of Fudan University | 90 | 2026-11-01 | 2026-10-22 |
| IVIG Boya: Safety, Efficacy, and Pharmacokinetics Boya IVIG - Primary Immunodeficiency Disease | Phase 3 | Not yet recruiting | Azidus Brasil | 50 | 2026-09-01 | 2026-06-03 |
| A Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP empasiprubart, IVIg, empasiprubart-placebo - Chronic Inflammatory Demyelinating Polyneuropathy, CIDP | Phase 3 | Recruiting | argenx | 218 | 2025-08-22 | 2026-11-16 |
| Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy Dosing Immunoglobulin (Dose Ig) Immune Globulin Intravenous - Myeloma, Non Hodgkin's Lymphoma | Phase 2 / Phase 3 | Recruiting | Monash University | 900 | 2025-04-28 | 2025-10-07 |
| A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) riliprubart, Placebo, IVIg - Chronic Inflammatory Demyelinating Polyneuropathy | Phase 3 | Recruiting | Sanofi | 160 | 2024-08-21 | 2026-10-19 |
| Efficacy, Safety, and Pharmacokinetics of Shu Yang IVIG IVIG - Primary Immunodeficiency Disease | Phase 3 | Unknown | Azidus Brasil | 50 | 2024-04-01 | 2024-03-12 |
| The Effects Of Therapeutic Plasma Exchange (TPE) On Age Related Biomarkers And Epigenetics Sham, Therapeutic Plasma Exchange, IVIG - Aging | Phase 3 | Unknown | Dobri Kiprov | 40 | 2022-09-12 | 2024-08-02 |
| Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx Imlifidase, PLEX, IVIg - Kidney Transplantation in Highly Sensitized Patients | Phase 3 | Completed | Hansa Biopharma AB | 64 | 2021-10-14 | 2026-04-30 |
| IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients plasmapheresis device, Intravenous immunoglobulin - Guillain-Barre Syndrome | Phase 2 / Phase 3 | Completed | Assiut University | 81 | 2021-09-01 | 2023-04-06 |
| Efficacy of Immunoglobulin Plus Infliximab for the Early Regression of Coronary Artery Lesion in Kawasaki Disease IVIG, Aspirin, Infliximab - Kawasaki Disease | Phase 3 | Withdrawn | Children's Hospital of Fudan University | 2020-10-01 | 2021-03-12 | |
| Surveillance and Treatment to Prevent Fetal Atrioventricular Block Likely to Occur Quickly (STOP BLOQ) Dexamethasone, IVIG - AVB - Atrioventricular Block, Fetal AVB | Phase 3 | Active not recruiting | NYU Langone Health | 1300 | 2020-08-01 | 2026-08-25 |
| rATG Versus rATG Combined With Intravenous Immunoglobulin (IVIG) Induction Immunosuppression in HLA Incompatible Transplantation (INHIBIT) Privigen, Thymoglobulin, Plasma Exchange - Kidney Transplantation | Phase 3 | Completed | Institute for Clinical and Experimental Medicine | 17 | 2020-07-27 | 2024-08-15 |
| Intravenous Immunoglobulin (IVIG, Bioven) Efficacy Assess for COVID-19 / SARS-CoV-2 Severe Pneumonia Complex Treatment IVIG - Covid19, Pneumonia | Phase 3 | Completed | Biopharma Plasma LLC | 76 | 2020-05-07 | 2020-10-14 |
| Efficacy of Immunoglobulin Plus Prednisolone in Reducing Coronary Artery Lesion in Patients With Kawasaki Disease IVIG, Aspirin, Prednisolone - Kawasaki Disease | Phase 3 | Completed | Children's Hospital of Fudan University | 3208 | 2020-01-15 | 2026-04-16 |
| Autologous Transplant To End NMO Spectrum Disorder Rituximab, Cyclophosphamide, Mesna - Neuromyelitis Optica, Devic's Disease | Phase 2 / Phase 3 | Withdrawn | Northwestern University | 2019-11-01 | 2019-11-20 | |
| Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children Eltrombopag, Steroids, IVIG - Immune Thrombocytopenia | Phase 3 | Completed | Baylor College of Medicine | 122 | 2019-05-02 | 2025-07-29 |
| Etoposide in the First-line Treatment of Adult EBV-HLH Etoposide, Dexamethasone, IVIG - Hemophagocytic Lymphohistiocytosis | Phase 3 | Unknown | Beijing Friendship Hospital | 90 | 2018-12-01 | 2018-11-15 |
| Cardiac Safe Transplants for Systemic Sclerosis Rituximab, Fludarabine, Cyclophosphamide - Systemic Sclerosis, Scleroderma | Phase 2 / Phase 3 | Terminated | Northwestern University | 9 | 2018-05-17 | 2020-08-12 |
| Maximizing Outcome of Multiple Sclerosis Transplantation Cyclophosphamide, Mesna, rATG - Multiple Sclerosis, Relapsing-Remitting | Phase 3 | Terminated | Northwestern University | 66 | 2017-11-08 | 2021-01-11 |
| KIDCARE (Kawasaki Disease Comparative Effectiveness Trial) IVIG, Infliximab - Mucocutaneous Lymph Node Syndrome | Phase 3 | Completed | University of California, San Diego | 105 | 2017-02-17 | 2021-12-03 |
Showing 20 of 26. Sign in to see all of them.
Mucocutaneous Lymph Node Syndrome (5) · Polyradiculoneuropathy, Chronic Inflammatory Demyelinating (3) · Primary Immunodeficiency Diseases (2) · Atrioventricular Block (1) · Bruton type agammaglobulinemia (1) · COVID-19 (1) · Common Variable Immunodeficiency (1) · Coronavirus Infections (1) · Guillain-Barre Syndrome (1) · Histiocytosis, Langerhans-Cell (1) · Infections (1) · Leukemia (1) · Lymphohistiocytosis, Hemophagocytic (1) · Lymphoma (1) · Meningitis (1)
Children's Hospital of Fudan University (3) · Northwestern University (3) · Azidus Brasil (2) · Assiut University (1) · Baylor College of Medicine (1) · Beijing Friendship Hospital (1) · Biopharma Plasma LLC (1) · Dobri Kiprov (1) · Fudan University (1) · Grifols Therapeutics LLC (1) · Hansa Biopharma AB (1) · Haukeland University Hospital (1) · Hormozgan University of Medical Sciences (1) · Institute for Clinical and Experimental Medicine (1) · Monash University (1)
United States (13) · China (6) · Canada (4) · Czechia (4) · Argentina (3) · Germany (3) · Israel (3) · Italy (3) · Australia (2) · Brazil (2) · France (2) · Greece (2) · Hungary (2) · Japan (2) · Mexico (2)
Richard Burt, MD (3) · Luciana Ferrara (2) · Amanda Grimes, MD (1) · Avroy A. Fanaroff, MD (1) · Bettina Cuneo, MD (1) · Carlos Rodriguez-Galindo, MD (1) · Charles R. Bauer, MD (1) · Dobri Kiprov, MD (1) · Elisabeth Farbu, MD, PhD (1) · Elizabeth C. Wright, PhD (1) · Fang Liu, MD (1) · Fang Liu, MD. (1) · Guoying Huang, MD. (1) · Jane C Burns, MD (1)
PMID 18178525, PMID 19260050, PMID 19365055, PMID 19496683, PMID 20457948, PMID 20647554, PMID 20837852, PMID 32612255, PMID 34452956, PMID 34715057, PMID 34895290, PMID 37947364, PMID 40424097, PMID 40458542, PMID 41123939, PMID 41985133, PMID 8133853, PMID 9686724
2023 (1), U01HD019897 (1), U10HD021364 (1), U10HD021373 (1), U10HD021385 (1), U10HD021397 (1), U10HD021415 (1)